Suppr超能文献

在一项为期12周的氟西汀开放试验中,对患有重度抑郁症的儿童和青少年中测量抗抑郁药物依从性的各种方法进行比较。

A comparison of various methods of measuring antidepressant medication adherence among children and adolescents with major depressive disorder in a 12-week open trial of fluoxetine.

作者信息

Nakonezny Paul A, Hughes Carroll W, Mayes Taryn L, Sternweis-Yang Kathryn H, Kennard Betsy D, Byerly Matthew J, Emslie Graham J

机构信息

Division of Biostatistics, Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, Texas 75390-8828, USA.

出版信息

J Child Adolesc Psychopharmacol. 2010 Oct;20(5):431-9. doi: 10.1089/cap.2009.0108.

Abstract

OBJECTIVE

In this study, we examined antidepressant (fluoxetine) medication adherence in children and adolescents with major depressive disorder (MDD). Using electronic monitoring (EM) as the "reference standard," we compared various methods of measuring antidepressant medication adherence (including EM, pill counts, and medication diaries) among children and adolescents with MDD and examined the relationship between EM medication adherence and depression severity across time. We then suggested recommendations for clinical researchers and practicing clinicians regarding medication adherence assessment.

METHOD

Thirty-one child and adolescent outpatients with MDD who enrolled in a 12-week open trial of fluoxetine had their antidepressant medication adherence assessed at each visit, using EM, pill counts, and parent and patient medication diaries. Depression severity was assessed by the Children's Depression Rating Scales-Revised at each visit.

RESULTS

Twelve-week least squares mean estimates of medication adherence for the entire sample was high, regardless of the adherence assessment method, although the overall adherence among the four methods (EM, pill, parent diary, patient diary) was significantly different (87.5% vs. 90.6% vs. 93.1% vs. 93.3%, respectively, p=0.0002). Adjusted mean symptom severity was significantly lower for the EM "adherent" group than for the EM "nonadherent" group over the 12 weeks of treatment (35.6 vs. 43.8, p=0.008).

CONCLUSION

Overall, EM medication adherence for the depressed youth in this study is high. Compared with EM, there is a tendency of pill counts and medication diaries to overestimate medication adherence. However, pill count adherence better approximates EM adherence, and compliance with returning medication diaries is poor. Youth who are adherent to fluoxetine treatment have lower symptom severity over the course of treatment. Recommendations are provided.

摘要

目的

在本研究中,我们调查了患有重度抑郁症(MDD)的儿童和青少年对抗抑郁药(氟西汀)的服药依从性。以电子监测(EM)作为“参考标准”,我们比较了测量MDD儿童和青少年抗抑郁药服药依从性的各种方法(包括EM、药片计数和用药日记),并研究了EM服药依从性与抑郁严重程度随时间的关系。然后,我们针对服药依从性评估向临床研究人员和执业临床医生提出了建议。

方法

31名参加氟西汀12周开放试验的患有MDD的儿童和青少年门诊患者,在每次就诊时使用EM、药片计数以及家长和患者用药日记来评估他们的抗抑郁药服药依从性。每次就诊时通过修订版儿童抑郁评定量表评估抑郁严重程度。

结果

整个样本12周的服药依从性最小二乘均值估计值较高,无论依从性评估方法如何,尽管四种方法(EM、药片、家长日记、患者日记)的总体依从性存在显著差异(分别为87.5%、90.6%、93.1%和93.3%,p = 0.0002)。在12周的治疗过程中,EM“依从”组的调整后平均症状严重程度显著低于EM“不依从”组(35.6对43.8,p = 0.008)。

结论

总体而言,本研究中抑郁青少年的EM服药依从性较高。与EM相比,药片计数和用药日记有高估服药依从性的倾向。然而,药片计数依从性更接近EM依从性,而交回用药日记的依从性较差。坚持氟西汀治疗的青少年在治疗过程中症状严重程度较低。本研究提供了相关建议。

相似文献

2
Symptom improvement and residual symptoms during acute antidepressant treatment in pediatric major depressive disorder.
J Child Adolesc Psychopharmacol. 2010 Oct;20(5):423-30. doi: 10.1089/cap.2009.0116.
3
Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial.
J Am Acad Child Adolesc Psychiatry. 2011 May;50(5):490-8. doi: 10.1016/j.jaac.2011.01.018. Epub 2011 Mar 9.
4
Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder.
J Child Adolesc Psychopharmacol. 2018 Feb;28(1):36-46. doi: 10.1089/cap.2017.0100. Epub 2017 Nov 30.
5
Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder.
J Am Acad Child Adolesc Psychiatry. 2009 Jan;48(1):71-8. doi: 10.1097/CHI.0b013e318190043e.
6
Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
J Psychopharmacol. 2002 Sep;16(3):215-9. doi: 10.1177/026988110201600304.
8
Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.
Drug Alcohol Depend. 2010 Nov 1;112(1-2):39-45. doi: 10.1016/j.drugalcdep.2010.05.010. Epub 2010 Jun 23.
9
Melancholic features in inpatients with major depressive disorder associate with differential clinical characteristics and treatment outcomes.
Psychiatry Res. 2016 Apr 30;238:368-373. doi: 10.1016/j.psychres.2015.11.009. Epub 2015 Nov 23.
10
Compliance in depressed patients treated with fluoxetine or amitriptyline. Belgian Compliance Study Group.
Int Clin Psychopharmacol. 1998 Jan;13(1):11-7. doi: 10.1097/00004850-199801000-00002.

引用本文的文献

1
Parental Factors Associated with Child or Adolescent Medication Adherence: A Systematic Review.
Healthcare (Basel). 2023 Feb 8;11(4):501. doi: 10.3390/healthcare11040501.
2
Comparison of Different Adherence Measures in Adolescent Outpatients with Depressive Disorder.
Patient Prefer Adherence. 2020 Jun 24;14:1065-1072. doi: 10.2147/PPA.S249728. eCollection 2020.
3
Adherence to Antidepressants in Underserved Communities: A Comparison of Electronic Monitoring and Self-report Measures.
Community Ment Health J. 2020 May;56(4):727-734. doi: 10.1007/s10597-019-00533-2. Epub 2020 Jan 1.
4
Assessing medication adherence: options to consider.
Int J Clin Pharm. 2014 Feb;36(1):55-69. doi: 10.1007/s11096-013-9865-x. Epub 2013 Oct 29.
7
Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial.
J Am Acad Child Adolesc Psychiatry. 2011 May;50(5):490-8. doi: 10.1016/j.jaac.2011.01.018. Epub 2011 Mar 9.

本文引用的文献

2
Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder.
J Am Acad Child Adolesc Psychiatry. 2009 Jan;48(1):71-8. doi: 10.1097/CHI.0b013e318190043e.
3
Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder.
J Am Acad Child Adolesc Psychiatry. 2008 Dec;47(12):1395-404. doi: 10.1097/CHI.0b013e31818914a1.
4
Tactics and technologies to manage nonadherence in patients with schizophrenia.
Curr Psychiatry Rep. 2008 Aug;10(4):359-69. doi: 10.1007/s11920-008-0057-7.
5
Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents.
Am J Psychiatry. 2008 Apr;165(4):459-67. doi: 10.1176/appi.ajp.2007.07091453. Epub 2008 Feb 15.
6
Practice parameter for the assessment and treatment of children and adolescents with depressive disorders.
J Am Acad Child Adolesc Psychiatry. 2007 Nov;46(11):1503-26. doi: 10.1097/chi.0b013e318145ae1c.
8
Relationships among subjective and objective measures of adherence to oral antipsychotic medications.
Psychiatr Serv. 2007 Sep;58(9):1187-92. doi: 10.1176/ps.2007.58.9.1187.
9
Antipsychotic medication adherence in schizophrenia.
Psychiatr Clin North Am. 2007 Sep;30(3):437-52. doi: 10.1016/j.psc.2007.04.002.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验